Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SANTHERA PHARMACEUTICALS HOLDING AG
01/04Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare..
DJ
01/04Santhera Pharmaceuticals Enters into Exclusive License Agreement with Sperogenix for Va..
CI
2021Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Me..
DJ
2021Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Me..
AQ
2021Santhera Pharmaceuticals Holding AG announced that it expects to receive CHF 20 million..
CI
2021Santhera to Host Investor Conference Call, Looking Ahead to 2022
AQ
2021Santhera to File Rolling New Drug Application for Duchenne Treatment to US FDA in Early..
MT
2021Santhera to Host Investor Conference Call — Looking Ahead to 2022
AQ
2021Santhera's Board Calls Extraordinary General Meeting To Vote On Future Fundraisings
MT
2021Santhera Provides Corporate Update and Calls Extraordinary General Meeting to Seek Appr..
DJ
2021Santhera Pharmaceuticals Holding AG announced that it has received CHF 15 million in fu..
CI
2021Santhera's Mid-Stage Trial For Duchenne Muscular Dystrophy Drug Shows Sustained Efficac..
MT
2021Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completi..
AQ
2021Santhera JV to Seek US FDA's New Drug Approval For Duchenne Muscular Dystrophy Treatmen..
MT
2021Santhera and ReveraGen Announce Successful FDA Pre-NDA Meeting for Vamorolone in Duchen..
DJ
More most relevant news
All news about SANTHERA PHARMACEUTICALS HOLDING AG
01/04Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare..
DJ
01/04Santhera Pharmaceuticals Enters into Exclusive License Agreement with Sperogenix for Va..
CI
2021Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Me..
DJ
2021Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Me..
AQ
2021Santhera Pharmaceuticals Holding AG announced that it expects to receive CHF 20 million..
CI
2021Santhera to Host Investor Conference Call, Looking Ahead to 2022
AQ
2021Santhera to File Rolling New Drug Application for Duchenne Treatment to US FDA in Early..
MT
2021Santhera to Host Investor Conference Call — Looking Ahead to 2022
AQ
2021Santhera's Board Calls Extraordinary General Meeting To Vote On Future Fundraisings
MT
2021Santhera Provides Corporate Update and Calls Extraordinary General Meeting to Seek Appr..
DJ
More news
News in other languages on SANTHERA PHARMACEUTICALS HOLDING AG
01/04SANTHERA : licence exclusive conclue avec Sperogenix pour le Vamorolone
01/04Santhera schliesst Lizenzabkommen für Vamorolone für Grossraum China ab
01/04Santhera schliesst exklusives Lizenzabkommen mit Sperogenix für Vamorolone zur Behandlu..
01/04Santhera Pharmaceuticals conclut un accord de licence exclusive avec Sperogenix pour la..
2021SANTHERA : les actionnaires approuvent l'augmentation de capital
2021Santhera-Aktionäre stimmen an aoGV weiterer Kapitalerhöhung zu
2021Santhera's Aktionäre stimmen an der heutigen ausserordentlichen Generalversammlung alle..
2021Santhera-CEO zeigt sich zuversichtlich für DMD-Mittel Vamorolone
2021Santhera optimiste pour son médicament vamorolone
2021Santhera déposera une demande d'autorisation de mise sur le marché d'un nouveau médicam..
More news
Press releases
2021Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Me..
AQ
2021Santhera to Host Investor Conference Call, Looking Ahead to 2022
AQ
2021Santhera to Host Investor Conference Call — Looking Ahead to 2022
AQ
2021Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completi..
AQ
2021Santhera Appoints Stephanie Brown as President North America and Member of the Executiv..
AQ
More press releases